Rules for identifying patients at increased risk for candidal infections in the surgical intensive care unit: approach to developing practical criteria for systematic use in antifungal prophylaxis trials
The DOI matches its Crossref record; 56 of the 57 references it cites were found in a registry or an index.
Abstract
The high rates of invasive candidiasis among intensive care unit (ICU) patients suggest that antifungal prophylaxis might be of value, but rules identifying patients who would best benefit are not established. Based on a retrospective study of 327 patients who stayed in a surgical ICU for > or = 4 days and had an 11.0% rate of invasive candidiasis, we sought to identify useful predictive rules. As prior work suggests that prompt initiation of prophylaxis is of value, we required our rules to be based on patient data routinely available during the week prior to ICU admission through the third day of the ICU stay. Patients with any combination of diabetes mellitus, new onset hemodialysis, use of total parenteral nutrition, or receipt of broad-spectrum antibiotics had an invasive candidiasis rate of 16.6% versus a 5.1% rate for patients lacking these characteristics (P = 0.001). Fifty-two percent of patients staying > or = 4 days in the ICU met this rule and the rule captured 78% of the patients who eventually developed invasive candidiasis. Risk-stratified antifungal prophylaxis in the ICU is possible. Validation of these results in other types of ICU is now needed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Possible risk factors have been evaluated in several studies and used to identify patients in need of pre-emptive or empiric treatment [32,33].”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [32]
Citations
Cites
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
J Antimicrob Chemother 1994; 33: 350–351
O'SHAUGHNESSY, E. M., & DAS, S. S. (1994) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/33.2.350 · Cited by 3,746
Infectious Diseases Society of America
Enders, J. F. (1969) · Journal of Infectious Diseases · doi:10.1093/infdis/119.3.317 · Cited by 3,286
Ascioglu, S., Rex, J. H., de Pauw, B., Bennett, J. E., Bille, J., Crokaert, F., Denning, D. W., Donnelly, J. P., Edwards, J. E., Erjavec, Z., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/323335 · Cited by 2,331
Self-citationGuidelines for the management of intravascular catheter-related infections
Mermel, L. A., Farr, B. M., Sherertz, R. J., Raad, I. I., O'Grady, N., Harris, J. S., & Craven, D. E. (2001) · Clinical Infectious Diseases · doi:10.1086/320001 · Cited by 1,449
Goodman, J. L., Winston, D. J., Greenfield, R. A., Chandrasekar, P. H., Fox, B., Kaizer, H., Shadduck, R. K., Shea, T. C., Stiff, P., Friedman, D. J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203263261301 · Cited by 1,174
Practice Guidelines for the Treatment of Candidiasis
Rex, J. H., Walsh, T. J., Sobel, J. D., Filler, S. G., Pappas, P. G., Dismukes, W. E., & Edwards, J. E. (2000) · Clinical Infectious Diseases · doi:10.1086/313749 · Cited by 927
Self-citationSlavin, M. A., Osborne, B., Adams, R., Levenstein, M. J., Schoch, H. G., Feldman, A. R., Meyers, J. D., & Bowden, R. A. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/171.6.1545 · Cited by 820
Candida Colonization and Subsequent Infections in Critically III Surgical Patients
Pittet, D., Monod, M., Suter, P. M., Frenk, E., & Auckenthaler, R. (1994) · Annals of Surgery · doi:10.1097/00000658-199412000-00008 · Cited by 798
Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality.
Fraser, V. J., Jones, M., Dunkel, J., Storfer, S., Medoff, G., & Dunagan, W. C. (1992) · Clinical Infectious Diseases · doi:10.1093/clind/15.3.414 · Cited by 679
Research works printed but not linked: 18
- Chen YC, 2001, J Formos Med Assoc, 100, 797
- Rangel-Frausto MS, 1999, Clin Infect Dis, 29, 258
- Vincent JL, 1998, Intensive Care Med, 24, 216
- Chen YC, 2001, J Formos Med Assoc, 100, 661
- Cornwell, 1995, Am Surg, 61, 850
- Rex JH, 2001, Clin Infect Dis, 32, 1200
- Pfaller MA, 1998, Diagn Microbiol Infect Dis, 31, 296
- Petri MG, 1997, Divisions of Mycology and Pneumonia Research. Intensive Care Med, 23, 325
- Marr KA, 2000, Blood, 96, 2061
- Pelz RK, 2001, Ann Surg, 233, 548
- Martins MD, 1996, New Horiz, 4, 344
- Sobel JD, 2001, Clin Infect Dis, 33, 190
- Blumberg HM, 2001, The National Epidemiology of Mycosis Survey. Clin Infect Dis, 33, 186
- Wey SB, 1989, Arch Intern Med, 149, 2353
- Wong DT, 1991, Can J Anaesth, 38, 383
- Mermel LA, 2001, J Intraven Nurs, 24, 205
- Bone RC, 1992, Chest, 101, 1655
- Fass RJ, 1996, J Antimicrob Chemother, 38, 916
Cited by
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174
“These risk-assessment strategies have been derived either from primary studies to determine risk factors or from clinical trials of prophylaxis (181), and they encompass selection (risk) criteria as simple as a Candida colonization index alone (232) or an ICU stay of 3 days (196) to more-complicated formulae, includin…”
BackgroundMethodInfluentialPappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191
Self-citationEpidemiology of Invasive Mycoses in North America
Pfaller, M. A., & Diekema, D. J. (2010) · Critical Reviews in Microbiology · doi:10.3109/10408410903241444 · Cited by 901
“Most authors recommend the use of clinical risk factors to identify patients who may benefit from prophylactic or empirical antifungal therapy in the proper clinical setting (Charles 2006; Kollef et al. 2008; Munoz et al. 2000; Ostrosky-Zeichner 2004; Paphitou et al. 2005; Procop et al. 2004; Rex.”
BackgroundThe Surgical Infection Society Revised Guidelines on the Management of Intra-Abdominal Infection
Mazuski, J. E., Tessier, J. M., May, A. K., Sawyer, R. G., Nadler, E. P., Rosengart, M. R., Chang, P. K., O'Neill, P. J., Mollen, K. P., Huston, J. M., et al. (2017) · Surgical Infections · doi:10.1089/sur.2016.261 · Cited by 573
Epidemiology of invasive candidiasis
Arendrup, M. C. (2010) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e32833e84d2 · Cited by 376
Metadata
- Authors
- Paphitou, N. I., Ostrosky-Zeichner, L., & Rex, J. H.
- Affiliations
- The University of Texas Health Science Center at Houston (US)
- Corresponding author
- Paphitou, Niki I.
- ORCID
- Rex, John H.
- Venue
- Medical Mycology
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-01
- Volume
- 43
- Issue
- 3
- Pages
- 235-243
- ISSN
- 0268-1218 (ISSN-L)
- 1369-3786
- 1460-2709
- OpenAlex
- W1979708960
- Cited by
- 179
- References
- 57
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 7 · 2023: 6 · 2022: 5 · 2021: 6 · 2020: 7 · 2019: 7 · 2018: 9 · 2017: 5 · 2016: 11 · 2015: 14 · 2014: 10 · 2013: 8 · 2012: 2
- FWCI
- 7.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Medical Mycology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
- Keywords
- invasive candidiasis, antifungal prophylaxis, surgical intensive care unit, risk stratification, predictive rules, diabetes mellitus, hemodialysis, total parenteral nutrition, broad-spectrum antibiotics, risk factors
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Candidiasis, Critical Care, Diabetes Mellitus, Female, Renal Dialysis, Humans, Length of Stay, Male, Middle Aged, Parenteral Nutrition, Total, Retrospective Studies, Risk Factors, Practice Guidelines as Topic, Antibiotic Prophylaxis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Rules for identifying patients at increased risk for candidal infections in the surgical intensive care unit: approach to developing practical criteria for systematic use in antifungal prophylaxis trials. https://app.cochat.ai/papers/10.1080/13693780410001731619
- The paper
- Paphitou, N. I., Ostrosky-Zeichner, L., & Rex, J. H. (2005). Rules for identifying patients at increased risk for candidal infections in the surgical intensive care unit: approach to developing practical criteria for systematic use in antifungal prophylaxis trials. Medical Mycology. https://doi.org/10.1080/13693780410001731619
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.